Grants

awarded

The METAvivor Research Program was established in 2009 with the specific goal of funding stage IV metastatic breast cancer research to one day, end death from metastatic breast cancer (MBC). The following list includes current and past grant recipients along with their progress reports.

Erin Howe, PhD

University of Notre Dame-Harper Cancer Research Institute

Presented in memory of Erin Remme by Minneapolis Metsquerade

Targeting endosomal trafficking to enhance immune recognition of breast cancer brain metastases

Quanyin HU, PhD

School of Pharmacy, University of Wisconsin-Madison

Presented In memory of Andi Myers and Elizabeth Seagraves Murray and those from the support group “Living with MBC in DENJPA”

Targeted degradation of BET proteins in combination with immune checkpoint inhibitors for treating metastatic triple-negative breast cancer

Barry Hudson, PhD

University of Miami

Presented in memory of Amanda De Fiebre by Southwest Florida Metsquerade

Therapeutic targeting of RAGE in metastatic breast cancer

Natasha Hunter, MD

University of Washington

Presented by Metavivor Facebook Fundraisers

Tissue and liquid biopsy for breast cancer patients with bone-only metastases

Douglas Hurst, PhD

University of Alabama at Birmingham, Alabama

Improving oncolytic herpes simplex virus for metastatic breast cancer

DOUGLAS HURST, Ph.D.

University of Alabama at Birmingham, Alabama

Improving oncolytic herpes simplex virus for metastatic breast cancer

Fumito Ito, MD, PhD

Roswell Park Comprehensive Cancer Center Health Research Inc

Presented by Southwest Florida Metsquerade in Memory of Karin Petrocelli

In situ radio-immunotherapy to maximize the engagement of cross-presenting dendritic cells to treat metastatic breast cancer

Rahul Jandial, MD, PhD

City of Hope Comprehensive Cancer Treatment Center in California

Disrupting metabolic adaptations in breast-to-brain metastases

Rinath Jeslesohn, MD

Dana Farber Cancer Institute

Presented by the Philadelphia METAvivor Gala in memory of Kerry O’Riordan McAdam and in honor of Jacqueline Beck

Integrative multi-omics and immune profiling with machine learning for optimization of treatment in metastatic hormone receptor positive breast cancer

Dennis Jones, PhD

Boston University

Presented by Metavivor Facebook Fundraisers

Targeting breast cancer plasticity and immunosuppression in metastatic lymph nodes

CHERYL JORCYK, PhD

Boise State University

High Impact Therapeutic for the Elimination of Breast Cancer Metastasis to Bone

Vadim Jucaud, PhD

Terasaki Institute for Biomedical Innovation

Presented by the Moore/Smith Family in memory of Carol Smith, wife, mother, friend and advocate

Microengineered approach to develop personalized monoclonal antibodies for metastatic breast cancer treatment